How do you formulate a baby sunscreen, and what U.S. OTC rules should buyers know?

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

• Baby sunscreen formulations prioritize mild, physical blockers such as zinc oxide or titanium dioxide to avoid skin irritation and provide broad-spectrum UV protection.
• These are often combined with emollients and soothing agents like aloe vera for infant skin compatibility.
• Avoid chemical filters that may cause allergies, and ensure hypoallergenic testing during development.
• From an OEM standpoint, we start with an RFQ to assess feasibility based on your target SPF level, texture preferences, and market claims.
• MOQs typically range from 10,000 to 50,000 units per SKU, driven by raw material batch sizes and production line efficiency.
• Sampling involves a 2-3 week lab phase for formula adjustments and a 4-6 week pilot run for commercial validation, with checks for viscosity and fill temperature to prevent separation.
• U.S.
• OTC rules mandate compliance with FDA’s Sunscreen Drug Products Final Rule, including GRASE ingredient lists and SPF testing per standardized protocols.
• Key documents include an OTC monograph for drug registration, drug facts panel for labeling, and stability data for shelf-life claims.
• We support with third-party testing for SPF, waterproofness, and microbial safety to meet USP standards.
• Packaging must feature child-resistant closures and BPA-free materials, with leak testing during filling.
• Lead time from order to shipment is 8-10 weeks, including stability hold periods and QA audits for batch consistency.
• We assist with documentation and testing but cannot guarantee regulatory approval; always consult a legal expert for final compliance.